These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11060590)
1. Genetic therapy for pain management. Wilson SP; Yeomans DC Curr Rev Pain; 2000; 4(6):445-50. PubMed ID: 11060590 [TBL] [Abstract][Full Text] [Related]
2. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Finegold AA; Mannes AJ; Iadarola MJ Hum Gene Ther; 1999 May; 10(7):1251-7. PubMed ID: 10340556 [TBL] [Abstract][Full Text] [Related]
3. Herpes vector-mediated gene transfer in the treatment of chronic pain. Glorioso JC; Fink DJ Mol Ther; 2009 Jan; 17(1):13-8. PubMed ID: 18841093 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 gene therapy of chronic neuropathic pain. Yao MZ; Gu JF; Wang JH; Sun LY; Lang MF; Liu J; Zhao ZQ; Liu XY Neuroscience; 2002; 112(2):409-16. PubMed ID: 12044458 [TBL] [Abstract][Full Text] [Related]
5. Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Cejas PJ; Martinez M; Karmally S; McKillop M; McKillop J; Plunkett JA; Oudega M; Eaton MJ Pain; 2000 May; 86(1-2):195-210. PubMed ID: 10779676 [TBL] [Abstract][Full Text] [Related]
7. Targeted gene delivery to the nervous system using herpes simplex virus vectors. Mata M; Glorioso JC; Fink DJ Physiol Behav; 2002 Dec; 77(4-5):483-8. PubMed ID: 12526987 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy of pain: emerging strategies and future directions. Pohl M; Braz J Eur J Pharmacol; 2001 Oct; 429(1-3):39-48. PubMed ID: 11698025 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice. Ma F; Wang C; Yoder WE; Westlund KN; Carlson CR; Miller CS; Danaher RJ J Oral Facial Pain Headache; 2016; 30(1):42-50. PubMed ID: 26817032 [TBL] [Abstract][Full Text] [Related]
10. Improvements in gene therapy: averting the immune response to adenoviral vectors. Ritter T; Lehmann M; Volk HD BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997 [TBL] [Abstract][Full Text] [Related]
12. Virally mediated delivery of enkephalin and other neuropeptide transgenes in experimental pain models. Wilson SP; Yeomans DC Ann N Y Acad Sci; 2002 Oct; 971():515-21. PubMed ID: 12438172 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated interleukin-2 gene therapy of nociception. Yao MZ; Gu JF; Wang JH; Sun LY; Liu H; Liu XY Gene Ther; 2003 Aug; 10(16):1392-9. PubMed ID: 12883536 [TBL] [Abstract][Full Text] [Related]
14. Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors. Glorioso JC; Mata M; Fink DJ Expert Opin Biol Ther; 2003 Dec; 3(8):1233-9. PubMed ID: 14640949 [TBL] [Abstract][Full Text] [Related]
15. Molecular approaches for neuropathic pain treatment. Siniscalco D; Rossi F; Maione S Curr Med Chem; 2007; 14(16):1783-7. PubMed ID: 17627516 [TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system. Zlokovic BV; Apuzzo ML Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854 [TBL] [Abstract][Full Text] [Related]
17. Applications of gene therapy to the treatment of chronic pain. Mata M; Hao S; Fink DJ Curr Gene Ther; 2008 Feb; 8(1):42-8. PubMed ID: 18336248 [TBL] [Abstract][Full Text] [Related]
18. Development of HSV-mediated gene transfer for the treatment of chronic pain. Mata M; Glorioso J; Fink DJ Exp Neurol; 2003 Nov; 184 Suppl 1():S25-9. PubMed ID: 14597322 [TBL] [Abstract][Full Text] [Related]